Photo taken from Christoph Zielinski/Twitter
Sep 2, 2023, 18:54
Christoph Zielinski: How can this inequality in treatment access be overcome?
In a post by Christoph Zielinski, the President of Central European Cooperative Oncology Group (CECOG), on X/Twitter, it says:
“Major advances have been made in highly effective treatment options in Her-2/neu overexpressing breast cancer. Yet, many compounds are not reimbursed and/or unavailable in many countries – also in Europe. How can this inequality in treatment access be overcome?”
Source: Christoph Zielinski/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 09:04
Dec 22, 2024, 07:59
Dec 22, 2024, 07:55
Dec 22, 2024, 07:44